Medication leaflets

Active substance

Results for the substance ephanesoctocog alfa

7 results

About this active substance

Efanesoctocog alfa is a medication used for the treatment of hemophilia A, a bleeding disorder caused by factor VIII deficiency. It is a recombinant factor VIII protein with extended action duration, helping to prevent and control bleeding episodes.

The medication is administered intravenously, usually according to a specific regimen established by the doctor. It is effective in reducing the frequency of bleeding episodes and improving the quality of life for patients with hemophilia A.

Side effects may include headache, nausea, injection site reactions, and, in rare cases, severe allergic reactions. Regular monitoring is essential to assess treatment effectiveness.

Consult your doctor to discuss the benefits and risks of treatment with Efanesoctocog alfa. Follow the administration instructions to ensure therapy effectiveness.